Fostering and Protecting Your Innovations

Search Our Technologies Search Our Forms

Upcoming Events

No events found for this month



Washington University Startup Developing σ-2 Targeted Cancer Therapy

By Tom on September 7, 2016

ST. LOUIS – In January 2016, Accuronix Therapeutics licensed a new class of drugs that work by selectively targeting σ (sigma)-2 receptors on cancer cells to deliver cytotoxic payloads. Accuronix was co-founded by Dr. William Hawkins at Wash...


Tioma Passes Series A Checkpoint with $86M

By Tom on September 1, 2016

BioGenerator, the Cortex-based evergreen investor that creates, grows and invests in promising companies and entrepreneurs, just announced its portfolio company Tioma Therapeutics (formerly Vasculox), has raised $86 million in a Series A venture f...